Genesis Capital
Private Equity Est. 2018
AUD 200M
Estimated FUM
- Type
- Private Equity
- HQ
- New South Wales, Australia
- Founded
- 2018
- Focus
- Healthcare
About
Genesis Capital is a leading lower mid-market private equity firm focused on the healthcare sector. We are active investors who work together with management teams to unlock growth in healthcare businesses that have the potential to be industry leaders.
• Healthcare experts: We firmly believe healthcare investing is best done by healthcare specialists. We live and breathe it and stick to what we know best.
• Business builders: We are business builders at heart and know what it takes to operate and grow lasting businesses. We find we get the best results are when we not only invest capital, but also our time and expertise to step-change a business's growth.
• Strong partners: We are business builders at heart and know what it takes to operate and grow lasting businesses. We find we get the best results are when we not only invest capital, but also our time and expertise to step-change a business's growth.
Strategies
Buyout
Breadth not publicly established
Growth Equity
Breadth not publicly established
Special Situations
Breadth not publicly established
Venture Capital
Breadth not publicly established
Private Credit
Breadth not publicly established
Investment Focus
Investment size
AUD 5M - AUD 50M
Reported investment size. Actual commitments may vary by stage, ownership and follow-on participation.
Focus Areas
Stages
Growth Series B
Focus
Healthcare
Investment Geographies
Primary Markets
Australia New Zealand
Coverage
Country-focused Regions
Oceania
Coverage is a guide only.
Location
Headquarters
New South Wales, Australia
Office Presence
1 country
Australia
1 known office
New South Wales, Australia (HQ)
Deals & Activity
Tracked Deals
2
Most common deal types
Unknown (2)
Recent tracked deals
Maps
2000
Leaders Program
People also viewed
Wattle Hill Capital
Wattle Hill RHC Fund is a specialist investment manager focused on private equity in the Australia and New Zealand region, delivering customised value-creating investment solutions for its global clients.
Headquartered in Sydney, with offices in Hong Kong and Beijing, Wattle Hill RHC is a private equity fund focused on investments in quality Australian businesses that offer products and services in demand by Chinese consumers. Wattle Hill RHC identifies leading enterprises that will benefit from China's economic growth and development then helps them prepare for and navigate Chinese market entry and expansion. Wattle Hill RHC is one of the only investment firms with a defined concurrent focus on the Chinese and Australian markets.
Wattle Hill RHC established its Australian fund in March 2016 with two of the largest insurance groups from China and Europe, as well as family-office investors from China's leading private e-commerce and FMCG companies. Wattle Hill RHC's Investment Committee includes one of Australia's most respected investors, Ashok Jacob of Ellerston Capital, and Sean Huang of Riverhead Capital, the private equity arm of Sunshine Insurance Group, one of China's largest privately-owned insurance groups with over 35 million direct policy holders.
Alceon Private Equity
Alceon Private Equity is a modern, ambitious and flexible private equity firm that does things a bit differently. We are diversely skilled business, operations and finance specialists within the $6 billion FUM Alceon Group.
We invest in mid-market growth companies where we believe we can help more effectively and rapidly realise those companies' potential and consequently deliver outstanding returns to shareholders, founders and investors. We use modern tools, processes and playbooks that build from historically proven approaches but evolved to suit the future, not the past.
As part of the successful Alceon Group, we have access to a large network of loyal investors with appetite to grow their wealth through investing in a variety of asset classes. Combined with Alceon Group's significant balance sheet, we think of this as our permanent capital. We then work with corporate advisers and company owners to identify high potential investment opportunities in which to deploy that capital as either a minority or majority stake. But we bring more than just money. We leverage our proven processes, governance and playbooks to work with our portfolio companies to level up their weaker operational areas and accelerate their growth plans. Unlike many of our competitors, we recognise each company has its own timeline so while we work to a successful exit, we do so on a schedule that will generate the best results for the business's shareholders.
Tritium Partners
Tritium Partners is a private equity firm focused on buyouts of growth companies in the lower middle market. Tritium's investment approach emphasizes acquiring majority positions in profitable companies and creating long-term value through internal growth initiatives and acquisitions, with a particular focus on three core sectors: internet and information services, asset-light supply chain and logistics, and differentiated financial and business services. We also create platform companies by combining smaller businesses in order to establish a strong financial profile, a compelling service offering, and an enthusiastic customer base from which to execute on our growth strategies. Tritium targets high-growth companies with strong management team. These businesses are typically generating $2m to $15m EBITDA at the time of our investment.
Adamantem Capital
Adamantem Capital is an Australian private equity firm investing in mid-market businesses across Australia and New Zealand through buyouts, growth capital and recapitalisations.
Graphite Capital
Graphite Capital is a UK mid-market private equity firm focused on three core sectors: health & pharma, education, and data & tech-enabled services, investing in companies valued between £30 million and £150 million.
Archer Capital
Archer Capital specialises in mid-market leveraged buyouts and is currently investing Archer Capital Fund 5. Archer Capital Fund 5 seeks mid-market LBO opportunities in Australia and New Zealand, favouring businesses with the opportunity to invest $75 million of equity or higher.
Archer Capital considers an active partnership with management throughout the lifecycle of an investment as an essential foundation for success. We acquire companies in equity partnership with management, either the incumbent management team or a buy-in team.
We assist managers to acquire or expand businesses by providing capital and, just as importantly, we actively support those managers to grow the value of their businesses and ultimately to realise that value. We bring operational expertise to our portfolio companies as well as financial and strategic capability.
The quality of a business is the key to the success of a transaction. Our expertise lies in identifying potential investment opportunities with businesses in a strong market position and/or with growth potential, with strong cash flows and significant opportunities to improve operational performance. Ultimately, our skill lies in increasing and realising the value of a business.
In April 2018, Archer Capital announced it would be winding up its operations.